Ningxia Zhongke Biotechnology Co., Ltd. (600165) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Ningxia Zhongke Biotechnology Co., Ltd.

Why is Ningxia Zhongke Biotechnology Co., Ltd. ?

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Net Sales has grown by an annual rate of 25.09% and Operating profit at -285.09% over the last 5 years
The company is Net-Debt Free

Negative results in Jun 26

OPERATING CASH FLOW(Y) Lowest at CNY -387.91 MM
PRE-TAX PROFIT(Q) At CNY -68.86 MM has Fallen at -85.75%
NET PROFIT(Q) At CNY -68.15 MM has Fallen at -200.84%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -18.89%, its profits have risen by 74%

Underperformed the market in the last 1 year

Even though the market (China Shanghai Composite) has generated returns of 3.40% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -18.89% returns

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Ningxia Zhongke Biotechnology Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Ningxia Zhongke Biotechnology Co., Ltd.

-17.38%

2.68

52.03%

China Shanghai Composite

3.23%

0.23

14.72%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

25.09%

EBIT Growth (5y)

-285.09%

EBIT to Interest (avg)

-4.54

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

32.15

Sales to Capital Employed (avg)

0.55

Tax Ratio

3.77%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

0.44%

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.67

EV to EBIT

-11.22

EV to EBITDA

-14.45

EV to Capital Employed

2.77

EV to Sales

10.23

PEG Ratio

Dividend Yield

ROCE (Latest)

-24.65%

ROE (Latest)

-13.46%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Mildly Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -29.47% (YoY

NET PROFIT(9M)

Higher at CNY 28.13 MM

NET SALES(Q)

Highest at CNY 156.72 MM

OPERATING PROFIT MARGIN(Q)

Highest at -22.12 %

-18What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY -387.91 MM

PRE-TAX PROFIT(Q)

At CNY -68.86 MM has Fallen at -85.75%

NET PROFIT(Q)

At CNY -68.15 MM has Fallen at -200.84%

INVENTORY TURNOVER RATIO(HY)

Lowest at 3.35 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.97 times

INTEREST(Q)

Highest at CNY 12.02 MM

Here's what is working for Ningxia Zhongke Biotechnology Co., Ltd.

Net Sales

At CNY 156.72 MM has Grown at 33.86%

over average net sales of the previous four periods of CNY 117.08 MM

MOJO Watch

Near term sales trend is very positive

Net Sales (CNY MM)

Net Sales

Highest at CNY 156.72 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Operating Profit Margin

Highest at -22.12 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Raw Material Cost

Fallen by -29.47% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Ningxia Zhongke Biotechnology Co., Ltd.

Pre-Tax Profit

At CNY -68.86 MM has Fallen at -85.75%

over average net sales of the previous four periods of CNY -37.07 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY -68.15 MM has Fallen at -200.84%

over average net sales of the previous four periods of CNY -22.65 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow

Lowest at CNY -387.91 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest

At CNY 12.02 MM has Grown at 458.7%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest

Highest at CNY 12.02 MM

in the last five periods and Increased by 458.7% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Inventory Turnover Ratio

Lowest at 3.35 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 2.97 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Footer loading